Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Mycoses 3Hematologic Neoplasms 3Leukemia 2Invasive Fungal Infections 2Infections 2Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1

Interventions

Cytarabine 4Peripheral Blood Stem Cell Transplantation 3Early Intervention, Educational 3Daunorubicin 3fludarabine phosphate 2Tretinoin 2Thioguanine 2Etoposide 2Cyclosporins 2valspodar 1hydrocortisone hemisuccinate 1Whole-Body Irradiation 1Voriconazole 1Therapeutics 1Psychiatric Rehabilitation 1Mycophenolic Acid 1Moxifloxacin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Hydroxyurea 1Hydrocortisone 1Fluconazole 1Filgrastim 1Decitabine 1Cyclosporine 1Biopsy 1Baclofen 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Myelodysplastic-Myeloproliferative Diseases × Voriconazole × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡